ToPCaP

Risk of thromboembolic disease in men with prostate cancer on androgen deprivation therapy: A follow-up study in PCBaSe Sweden.

O’Farrell, Sandstrom K, Garmo H, Stattin P, Holmberg L, Adolfsson J, Van Hemelrijck M. Risk of thromboembolic disease in men with prostate cancer on androgen deprivation therapy: A follow-up study in PCBaSe Sweden. BJUI (2015): In press.